
    
      Subjects will receive 90 mg GC4419 per day (60 min IV infusion to complete within 60 minutes
      prior to IMRT), concurrent with daily fractions of IMRT (2.0-2.2 Gy) to a total of 60-72 Gy
      over approximately 7 weeks, plus cisplatin administered 100 mg/m2 once every three weeks for
      3 doses or 40 mg/m2 once weekly for 6-7 doses (Investigator's choice).

      All subjects will be assessed twice weekly for OM per WHO grading criteria until 28 days post
      end of study treatment period (last day of IMRT).
    
  